AngioSoma Launching Holiday Awareness Campaign
November 12, 2018 07:00 ET
|
AngioSoma, Inc.
Heart Health Focused Campaign Set to Kick Off December 1st, 2018 HOUSTON, TX, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma (OTC: SOAN), a leading biotechnology research and...
StemStrength Deluxe Now Available on Amazon.com
October 22, 2018 06:00 ET
|
AngioSoma, Inc.
SomaCeuticals, an AngioSoma Inc. Subsidiary, Leverages Online Retail Giant for New Deluxe Formula of its Flagship Product HOUSTON, TX, Oct. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –...
AngioSoma, Inc. Announces Selection of Regulatory Firm for Flagship Drug
June 18, 2018 11:44 ET
|
AngioSoma, Inc.
HOUSTON, TX, June 18, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (SOAN) is excited to announce that we have identified a regulatory firm who can assist taking our patented flagship drug, Liprostin™,...
AngioSoma, Inc. Announces Grant of Patent for Flagship Drug
May 14, 2018 12:13 ET
|
AngioSoma, Inc.
HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to announce that the U.S. Patent Office has agreed to grant our patent application for our flagship...